Zacks Research Reduces Earnings Estimates for Henry Schein
Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued to ...
Le Lézard13d
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that ...
Le Lézard13d
PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company ...
American Association of Individual Investors3d
Which Is a Better Investment, BrightSpring Health Services, Inc. or Henry Schein, Inc. Stock?
Learn more about whether BrightSpring Health Services, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Yahoo Finance13d
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
MELVILLE, N.Y., March 11, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners ...
Henry Schein Inc. stock underperforms Wednesday when compared to competitors
Shares of Henry Schein Inc. HSIC slipped 1.61% to $70.84 Wednesday, on what proved to be an all-around great trading session ...
TMCnet13d
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...
HME News10d
Henry Schein makes advance in ‘particularly attractive’ CGM market
The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes ...